Quick Answer
UNITED THERAPEUTICS Corp reported Revenue From Contract With Customer Excluding Assessed Tax of $3.18 billion for the year ending 2025.
- UNITED THERAPEUTICS Corp showed an increase of +10.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from UNITED THERAPEUTICS Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), UNITED THERAPEUTICS Corp's Revenue From Contract With Customer Excluding Assessed Tax has grown by 99.1%.
- Historical annual values: Fiscal year 2025: $3.18 billion | Fiscal year 2024: $2.88 billion | Fiscal year 2023: $2.33 billion | Fiscal year 2022: $1.94 billion | Fiscal year 2021: $1.69 billion | Fiscal year 2020: $1.48 billion | Fiscal year 2019: $1.45 billion | Fiscal year 2018: $1.63 billion | Fiscal year 2017: $1.73 billion | Fiscal year 2016: $1.60 billion.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: